{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:45:05Z","timestamp":1789609505632,"version":"build-2803163510"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":49,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Patients with hematological malignancies (HMs) are at high risk of bloodstream infections (BSIs) during episodes of febrile neutropenia (FN). However, empirical treatment initiated before isolation of the causative agent from blood cultures is crucial. The aim of this study was to determine the distribution and antimicrobial resistance profile of microorganisms isolated from BSIs in patients with HMs, and to evaluate the association with the need for intensive care unit (ICU) and mortality at 30 days.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Single-centre data from patients with HMs who were admitted to the hematology inpatient clinic and had a BSI during an episode of FN were retrospectively reviewed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 164 FN episodes with BSI in 122 patients were analysed. Of the 164 episodes, 56.7% were Gram-negative. The most prevalent Gram-negative bacterium was\n                      <jats:italic>Escherichia coli<\/jats:italic>\n                      (31%). The positivity rate for extended-spectrum beta-lactamase (ESBL) was 49.3%, and the rate of carbapenem resistance was 20.2%. In multivariate analyses restricted to Gram-negative BSIs, carbapenem resistance was independently associated with both 30-day ICU admission and 30-day all-cause mortality, whereas ESBL positivity was not independently associated.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The rates of ESBL positivity and carbapenem resistance in Gram-negative bacteria are notable. However, only carbapenem resistance was independently associated with adverse clinical outcomes. Therefore, in line with regional surveillance data, empirical antibiotic strategies should take into account local resistance patterns, particularly carbapenem resistance, in FN episodes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-026-13465-6","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T10:37:06Z","timestamp":1777459026000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Evaluation of bloodstream infections in febrile neutropenic patients with hematological malignancy: a retrospective cohort study"],"prefix":"10.1186","volume":"26","author":[{"given":"Muhammet Salih","family":"Tarhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuf Emre","family":"\u00d6zdemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laden","family":"\u00c7amber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fehmi","family":"Hindilerden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emine","family":"G\u00fclt\u00fcrk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Habip","family":"Gedik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kadriye","family":"Kart Ya\u015far","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"issue":"7","key":"13465_CR1","doi-asserted-by":"publisher","first-page":"3799","DOI":"10.1128\/AAC.02561-14","volume":"58","author":"RG Rosa","year":"2014","unstructured":"Rosa RG, Goldani LZ. Cohort study of the impact of time to antibiotic administration on mortality in patients with febrile neutropenia. Antimicrob Agents Chemother. 2014;58(7):3799\u2013803. https:\/\/doi.org\/10.1128\/AAC.02561-14.","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 4","key":"13465_CR2","doi-asserted-by":"publisher","first-page":"S240","DOI":"10.1086\/427329","volume":"40","author":"C Viscoli","year":"2005","unstructured":"Viscoli C, Varnier O, Machetti M. Infections in patients with febrile neutropenia: epidemiology, microbiology, and risk stratification. Clin Infect Dis. 2005;40(Suppl 4):S240\u20135. https:\/\/doi.org\/10.1086\/427329.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"13465_CR3","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1378\/chest.129.6.1432","volume":"129","author":"PA Danai","year":"2006","unstructured":"Danai PA, Moss M, Mannino DM, Martin GS. The epidemiology of sepsis in patients with malignancy. Chest. 2006;129(6):1432\u201340. https:\/\/doi.org\/10.1378\/chest.129.6.1432.","journal-title":"Chest"},{"key":"13465_CR4","doi-asserted-by":"publisher","first-page":"S121","DOI":"10.1016\/j.pathol.2023.12.398","volume":"56","author":"I Freelander","year":"2024","unstructured":"Freelander I, Samarasekara H. Bloodstream infections in haematology\/oncology patients: a 5-year retrospective data analysis. Pathology. 2024;56:S121. https:\/\/doi.org\/10.1016\/j.pathol.2023.12.398.","journal-title":"Pathology"},{"issue":"4","key":"13465_CR5","doi-asserted-by":"publisher","first-page":"464","DOI":"10.4103\/0019-509X.175330","volume":"51","author":"LA Jacob","year":"2014","unstructured":"Jacob LA, Lakshmaiah KC, Govindbabu K, Suresh TM, Lokanatha D, Sinha M, et al. Clinical and microbiological profile of febrile neutropenia in solid tumors and hematological malignancies at a tertiary cancer care center in South India. Indian J Cancer. 2014;51(4):464\u20138. https:\/\/doi.org\/10.4103\/0019-509X.175330.","journal-title":"Indian J Cancer"},{"issue":"14","key":"13465_CR6","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1200\/JCO.2017.77.6211","volume":"36","author":"RA Taplitz","year":"2018","unstructured":"Taplitz RA, Kennedy EB, Bow EJ, Crews J, Gleason C, Hawley DK, et al. Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update. J Clin Oncol. 2018;36(14):1443\u201353. https:\/\/doi.org\/10.1200\/JCO.2017.77.6211.","journal-title":"J Clin Oncol"},{"key":"13465_CR7","unstructured":"EUCAST. Clinical breakpoints and dosing of antibiotics [Internet]. Available from: https:\/\/www.eucast.org\/clinical_breakpoints. Accessed in 2025 (Jan 2)."},{"issue":"9","key":"13465_CR8","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1086\/374339","volume":"36","author":"H Wisplinghoff","year":"2003","unstructured":"Wisplinghoff H, Seifert H, Wenzel RP, Edmond MB. Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States. Clin Infect Dis. 2003;36(9):1103\u201310. https:\/\/doi.org\/10.1086\/374339.","journal-title":"Clin Infect Dis"},{"key":"13465_CR9","doi-asserted-by":"publisher","unstructured":"Paul M, Bhatia M, Rekha US, Diksha BJ, Gupta P. Microbiological profile of bloodstream infections in febrile neutropenic patients at a tertiary care teaching hospital in Rishikesh, Uttarakhand. J Lab Physicians. 2020;12(2):147\u2013153. https:\/\/doi.org\/10.1055\/s-0040-1716661","DOI":"10.1055\/s-0040-1716661"},{"issue":"2","key":"13465_CR10","doi-asserted-by":"publisher","first-page":"340","DOI":"10.3947\/ic.2022.0069","volume":"54","author":"H Choi","year":"2022","unstructured":"Choi H, Ahn H, Lee R, Cho SY, Lee DG. Bloodstream Infections in Patients with Hematologic Diseases: Causative Organisms and Factors Associated with Resistance. Infect Chemother. 2022;54(2):340\u201352. https:\/\/doi.org\/10.3947\/ic.2022.0069.","journal-title":"Infect Chemother"},{"issue":"4","key":"13465_CR11","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s15010-018-1151-3","volume":"46","author":"Y Tang","year":"2018","unstructured":"Tang Y, Cheng Q, Yang Q, Liu J, Zhang D, Cao W, et al. Prognostic factors and scoring model of hematological malignancies patients with bloodstream infections. Infection. 2018;46(4):513\u201321. https:\/\/doi.org\/10.1007\/s15010-018-1151-3.","journal-title":"Infection"},{"issue":"4","key":"13465_CR12","doi-asserted-by":"publisher","first-page":"276","DOI":"10.22088\/cjim.8.4.276","volume":"8","author":"H Gedik","year":"2017","unstructured":"Gedik H. Antibiotic resistance status and its costs in hematological patients: A two-year analysis. Casp J Intern Med. 2017;8(4):276\u201381. https:\/\/doi.org\/10.22088\/cjim.8.4.276.","journal-title":"Casp J Intern Med"},{"issue":"1","key":"13465_CR13","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.idh.2019.08.006","volume":"25","author":"AS Carvalho","year":"2020","unstructured":"Carvalho AS, Lagana D, Catford J, Shaw D, Bak N. Bloodstream infections in neutropenic patients with haematological malignancies. Infect Dis Health. 2020;25(1):22\u20139. https:\/\/doi.org\/10.1016\/j.idh.2019.08.006.","journal-title":"Infect Dis Health"},{"issue":"1","key":"13465_CR14","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3947\/ic.2013.45.1.51","volume":"45","author":"JC Kwon","year":"2013","unstructured":"Kwon JC, Kim SH, Choi JK, Cho SY, Park YJ, Park SH, et al. Epidemiology and clinical features of bloodstream infections in hematology wards: one year experience at the catholic blood and marrow transplantation center. Infect Chemother. 2013;45(1):51\u201361. https:\/\/doi.org\/10.3947\/ic.2013.45.1.51.","journal-title":"Infect Chemother"},{"issue":"5","key":"13465_CR15","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/j.1469-0691.2012.03879.x","volume":"19","author":"C Gudiol","year":"2013","unstructured":"Gudiol C, Bodro M, Simonetti A, Tubau F, Gonz\u00e1lez-Barca E, Cisnal M, et al. Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients. Clin Microbiol Infect. 2013;19(5):474\u20139. https:\/\/doi.org\/10.1111\/j.1469-0691.2012.03879.x.","journal-title":"Clin Microbiol Infect"},{"key":"13465_CR16","first-page":"88","volume":"22","author":"AA Hamidi","year":"2009","unstructured":"Hamidi AA, Basaran S, Cagatay AA, Ozsut H, Atay K, Avsar N, et al. Organisms Isolated from Blood Cultures, Their Antimicrobial Susceptibilities and Patient Characteristics in Patients with Febrile Neutropenia. Klimik. 2009;22:88\u201391.","journal-title":"Klimik"},{"issue":"10","key":"13465_CR17","doi-asserted-by":"publisher","first-page":"686","DOI":"10.3109\/23744235.2015.1051105","volume":"47","author":"\u00d6 Kara","year":"2015","unstructured":"Kara \u00d6, Zarakolu P, A\u015f\u00e7io\u011flu S, Etg\u00fcl S, Uz B, B\u00fcy\u00fcka\u015fik Y, et al. Epidemiology and emerging resistance in bacterial bloodstream infections in patients with hematologic malignancies. Infect Dis (Lond). 2015;47(10):686\u201393. https:\/\/doi.org\/10.3109\/23744235.2015.1051105.","journal-title":"Infect Dis (Lond)"},{"issue":"1","key":"13465_CR18","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.jiph.2023.11.017","volume":"17","author":"H El Omri","year":"2024","unstructured":"El Omri H, Padmanabhan R, Taha RY, Kassem N, Elsabah H, Ellahie AY, et al. Dissecting bloodstream infections in febrile neutropenic patients with hematological malignancies, a decade-long single center retrospective observational study (2009\u20132019). J Infect Public Health. 2024;17(1):152\u201362. https:\/\/doi.org\/10.1016\/j.jiph.2023.11.017.","journal-title":"J Infect Public Health"},{"issue":"2","key":"13465_CR19","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1007\/s12032-011-9858-3","volume":"29","author":"I Ghosh","year":"2012","unstructured":"Ghosh I, Raina V, Kumar L, Sharma A, Bakhshi S, Thulkar S, et al. Profile of infections and outcome in high-risk febrile neutropenia: experience from a tertiary care cancer center in India. Med Oncol. 2012;29(2):1354\u201360. https:\/\/doi.org\/10.1007\/s12032-011-9858-3.","journal-title":"Med Oncol"},{"issue":"8","key":"13465_CR20","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1007\/s00277-020-04144-w","volume":"99","author":"R Kara Ali","year":"2020","unstructured":"Kara Ali R, Surme S, Balkan II, Salihoglu A, Sahin Ozdemir M, Ozdemir Y, et al. An eleven-year cohort of bloodstream infections in 552 febrile neutropenic patients: resistance profiles of Gram-negative bacteria as a predictor of mortality. Ann Hematol. 2020;99(8):1925\u201332. https:\/\/doi.org\/10.1007\/s00277-020-04144-w.","journal-title":"Ann Hematol"},{"issue":"4","key":"13465_CR21","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.cmi.2014.11.022","volume":"21","author":"EM Trecarichi","year":"2015","unstructured":"Trecarichi EM, Pagano L, Candoni A, Pastore D, Cattaneo C, Fanci R, et al. HeMABIS Registry-SEIFEM Group, Current epidemiology and antimicrobial resistance data for bacterial bloodstream infections in patients with hematologic malignancies: an Italian multicentre prospective survey. Clin Microbiol Infect. 2015;21(4):337\u201343. https:\/\/doi.org\/10.1016\/j.cmi.2014.11.022.","journal-title":"Clin Microbiol Infect"},{"issue":"8","key":"13465_CR22","doi-asserted-by":"publisher","first-page":"727","DOI":"10.3855\/jidc.11457","volume":"13","author":"D Mert","year":"2019","unstructured":"Mert D, Ceken S, Iskender G, Iskender D, Merdin A, Duygu F, et al. Epidemiology and mortality in bacterial bloodstream infections in patients with hematologic malignancies. J Infect Dev Ctries. 2019;13(8):727\u201335. https:\/\/doi.org\/10.3855\/jidc.11457.","journal-title":"J Infect Dev Ctries"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13465-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13465-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13465-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T01:56:40Z","timestamp":1781661400000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13465-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13465"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13465-6","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"assertion":[{"value":"29 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Clinical Research Ethics Committee of Bakirkoy Dr. Sadi Konuk Training and Research Hospital (Approval No: 2024-02-01; Protocol Code: 2024\/119). In accordance with national regulations (Turkish Ministry of Health Regulation on Clinical Research and the Law on the Protection of Personal Data No. 6698), informed consent was not required because the study was retrospective and all data were anonymized. The study was conducted in compliance with the ethical principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1152"}}